Human Trial of mRNA Universal Flu Vaccine Begins
A Phase 1 trail of a universal mRNA-based influenza vaccine is under way at Duke Unversity in Durham, North Carolina. It’s being developed by the National Institute of Allergy and Infectious Diseases’ (NAID) Vaccine Research Center (VRC). Some 50 participants aged 18-49 will be split into three groups and given Read more…






